Quarterly Updates12 May 2026, 05:21 pm
Neuland Labs Q4FY26: Total Income ₹2053.1 Cr, EBITDA ₹603.4 Cr
AI Summary
Neuland Laboratories Ltd (NLL) announced its financial results for the quarter and year ended March 31, 2026. Total income for Q4FY26 stood at ₹788.7 crore, a 134.9% increase YoY, and EBITDA was ₹319.4 crore, up by 448.6% YoY. The company reported a profit after tax of ₹212.5 crore, a 666.3% increase compared to Q4FY25. An error in the earnings call link was corrected and a new link provided. The company's CEO, Saharsh Davuluri, expressed satisfaction with the FY26 performance and highlighted investments in peptide manufacturing and a new R&D center.
Key Highlights
- Q4FY26 total income increased by 134.9% YoY to ₹788.7 crore.
- EBITDA for Q4FY26 surged by 448.6% YoY to ₹319.4 crore.
- Profit After Tax for Q4FY26 rose by 666.3% YoY to ₹212.5 crore.
- Company ended FY26 on a strong note with good business visibility.
- Investments in Peptide Manufacturing and new R&D Centre are proceeding as planned.